Clinical Trial Update: Resistant Hypertension Optimal Treatment [Phase 4]

View source ↗

Summary

An update on the Phase 4 Resistant Hypertension Optimal Treatment trial (NCT01643434) sponsored by Instituto do Coracao; the trial investigates treatment strate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Instituto do Coracao | Conditions: Hypertension | Phase 4 | Status: UNKNOWN